CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Gender-dependent differences in the efficacy and safety of Boceprevir triple therapy in German real-life
DOI 10.1055/s-0035-1559172
Bibliografische Angaben
Nachweis in CareLit
Autor:innenP Buggisch, H Löhr, G Teuber, H Steffens, M Kraus, C John, P Geyer, B Weber, T Witthöft, A Herrmann, M Hoesl, U Naumann, E Zehnter, D Hartmann, B Dreher, M Bilzer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Since 2011, triple therapy with the HCV protease inhibitor boceprevir (BOC) is widely used as standard of care for patients (pts) with chronic HCV G1 infection. Until now, there is limited information about the efficacy and safety of BOC triple therapy in clinical practice and whether differences occur between female and male pts. Methods: From April 2012 until January 2014, 536 pts with HCV G1 infection…
Zitieren
Zitierempfehlung
P Buggisch, H Löhr, G Teuber, H Steffens, M Kraus, C John, P Geyer, B Weber, T Witthöft, A Herrmann, M Hoesl, U Naumann, E Zehnter, D Hartmann, B Dreher, M Bilzer (2015) Gender-dependent differences in the efficacy and safety of Boceprevir triple therapy in German real-life. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0035-1559172
Mit CareLit weiterarbeiten